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C/EBP homologous protein contributes to
cytokine-induced pro-inflammatory responses
and apoptosis in b-cells
F Allagnat1,2, M Fukaya1, TC Nogueira1, D Delaroche1, N Welsh3, L Marselli4, P Marchetti4, JA Haefliger2, DL Eizirik1 and AK Cardozo*,1
Induction of the C/EBP homologous protein (CHOP) is considered a key event for endoplasmic reticulum (ER) stress-mediated
apoptosis. Type 1 diabetes (T1D) is characterized by an autoimmune destruction of the pancreatic b-cells. Pro-inflammatory
cytokines are early mediators of b-cell death in T1D. Cytokines induce ER stress and CHOP overexpression in b-cells, but the
role for CHOP overexpression in cytokine-induced b-cell apoptosis remains controversial. We presently observed that CHOP
knockdown (KD) prevents cytokine-mediated degradation of the anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2) and myeloid
cell leukemia sequence 1 (Mcl-1), thereby decreasing the cleavage of executioner caspases 9 and 3, and apoptosis. Nuclear
factor-jB (NF-jB) is a crucial transcription factor regulating b-cell apoptosis and inflammation. CHOP KD resulted in reduced
cytokine-induced NF-jB activity and expression of key NF-jB target genes involved in apoptosis and inflammation, including
iNOS, FAS, IRF-7, IL-15, CCL5 and CXCL10. This was due to decreased IjB degradation and p65 translocation to the nucleus.
The present data suggest that CHOP has a dual role in promoting b-cell death: (1) CHOP directly contributes to cytokine-induced
b-cell apoptosis by promoting cytokine-induced mitochondrial pathways of apoptosis; and (2) by supporting the NF-jB activation
and subsequent cytokine/chemokine expression, CHOP may contribute to apoptosis and the chemo attraction of mononuclear
cells to the islets during insulitis.
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Type 1 diabetes (T1D) is a severe chronic disease resulting
from an autoimmune destruction of the pancreatic b-cells. The
incidence of T1D has been rising steadily in developed
countries from the 1950s to the present day, with the recent,
alarming prediction that it will double in children under the age
of 5 years by 2020.1 b-cell loss in T1DM occurs slowly over
years and480% of the b-cell mass is usually lost at the time
of diagnosis. Because of the excessive mortality associated
with complications of T1D and the increasing incidence of
childhood diabetes,2 there is an ongoing effort to develop
novel strategies for a better treatment and hopefully, preven-
tion of T1D.
In T1D, b-cells cooperate with the immune system to its own
destruction by activating pro-apoptotic pathways and secret-
ing chemokines/cytokines that contribute to islet inflamma-
tion.3 These responses are mostly triggered via the secretion
of the pro-inflammatory cytokines interleukin-1b (IL-1b),
tumor necrosis factor-a (TNF-a) and interferon-g (IFN-g) by
the infiltrated immune cells. The mechanisms regulating
cytokine-mediated b-cell apoptosis and pro-inflammatory
responses are intricate and include, but are not restricted to,
the activation of the transcription factors nuclear factor-kB
(NF-kB) and STAT-1, the c-Jun N-terminal kinases (JNK),
endoplasmic reticulum (ER) stress pathways and the intrinsic
mitochondrial apoptotic pathways.3–7
NF-kB activation is due to cytokine-dependent activation of
the inhibitor of k-light polypeptide gene enhancer in B-cells
(IkB) kinase (IKK) complex (IKKa, IKKb and IKKg), which
leads to IkB phosphorylation, ubiquitination and proteasomal
degradation, releasing NF-kB for migration to the nucleus
where it can drive gene expression.8 NF-kB stimulates the
expression of several chemokines and cytokines in b-cells,
thereby contributing to islet inflammation in T1D.3 Although
NF-kB induces survival pathways in several cells types, it has
mostly a pro-apoptotic role in b-cells. The pro-apoptotic effect
of NF-kB in b-cells is, at least partly, due to induction of
TNF receptor superfamily member 6 (FAS) and the inducible
nitric oxide (NO) synthase (iNOS). Excessive NO production
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depletes ER calcium, inducing ER stress and activating the
unfolded protein response (UPR) in b-cells.9 The UPR
involves translational attenuation, increase in the folding
capacity of the ER by upregulation of ER chaperones,
degradation of misfolded proteins and, in severe cases,
apoptosis. The main UPR signaling cascades are initiated by
three ER-localized protein sensors: IRE1a (inositol-requiring
1a), PERK (double-stranded RNA-dependent protein kinase -
like ER kinase) and ATF6 (activating transcription factor 6).
PERK phosphorylates the eukaryotic translation initiation
factor subunit-a (eIF2a), resulting in reduction of the general
protein synthesis rate while favoring the translation of
selective genes, including the transcription factor ATF4,
which stimulates the expression of the C/EBP homologous
protein (CHOP). Several studies point to a pro-apoptotic role
for CHOP downstream of severe ER stress.4,10 Besides its
pro-apoptotic role, recent studies also indicated a pro-
inflammatory role for CHOP.11–13
It is well established that cytokines induce ER stress in
b-cells.4 However, the role of ER stress in cytokine-induced
b-cell apoptosis remains controversial. We have recently shown
that ER stress contributes to b-cell apoptosis via PERK-
mediated downregulation of myeloid cell leukemia sequence
1 (Mcl-1), an important anti-apoptotic protein from the B-cell
lymphoma 2 (Bcl-2) family that regulates the mitochondrial
apoptotic pathway.14 Some studies suggest that CHOP and
binding immunoglobulin protein (BiP) have, respectively, pro-
and anti-apoptotic roles in this process, but others failed to find
an association between CHOP and cytokine-induced b-cell
death.15–17 Moreover, the molecular mechanisms underlying
ER stress- and CHOP-induced apoptosis are still unclear.4,10
Against this background, the goal of this study was to
determine whether CHOP is involved in cytokine-induced
apoptosis and inflammation in b-cells, and if so, what are the
mechanisms involved. We observed that knocking down
CHOP delayed cytokine-induced apoptosis in an insulinoma
cell line (INS-1E cells), fluorescence-activated cell sorting
(FACS)-purified rat b-cells and human islets. Moreover,
CHOP knock-down (KD) resulted in decreased NF-kB activity
due to decreased IkB degradation and subsequent p65
translocation to the nucleus. This correlated with decreased
cytokine-driven induction of keyNF-kB target genes, including
iNOS, FAS and several important chemokines. We further
observed that knocking down CHOP prevented cytokine-
mediated degradation of the anti-apoptotic proteins Bcl-2 and
Mcl-1, thereby decreasing cytochrome c release from the
mitochondria, subsequent cleavage of executioner caspases
9 and 3, and apoptosis. These observations suggest a role for
CHOP in two key mechanisms of b-cell loss in T1D, namely
apoptosis and local islet inflammation (insulitis).
Results
To evaluate the effect of pro-inflammatory cytokines onCHOP
expression, time-course experiments of TNF-aþ IFN-g or
IL-1bþ IFN-g treatment were conducted in INS-1E cells
(Figure 1a, see Supplementary Figure S1A for quantification).
Both TNF-aþ IFN-g or IL-1bþ IFN-g induced CHOP protein
after 8 h of treatment, with a peak around 16–24h. Similar
experiments were performed in isolated human islets, where
CHOP mRNA expression was induced after 24 h and
maintained after 48 h treatment (Figure 1b). In contrast with
INS-1E cells, TNF-aþ IFN-g induced higher levels of CHOP
mRNA than IL-1bþ IFN-g in human islet cells. The same
pattern of expression was observed for BiP (Supplementary
Figure S2A). Moreover, only a combination of TNF-aþ IFN-g
induced XBP-1 splicing in human islets (Supplementary
Figure S2B).
To elucidate the role of CHOP in cytokine-induced b-cells
apoptosis, INS-1E cells were transfected with two small
interference RNAs (siRNAs) targeting the rat CHOP. Both
siRNAs decreased by about 80% cyclopiazonic acid (CPA)-
induced CHOP protein overexpression (Figure 1c, see
quantification in Supplementary Figure S1B). We confirmed
at the mRNA level that transfection of the CHOPsiRNA#1
prevented both TNF-aþ IFN-g- or IL-1bþ IFN-g-induced
overexpression of CHOP (Supplementary Figure S1C) and
its target gene growth arrest and DNA damage 34 (GADD34)
(Supplementary Figure S1D) in INS-1E cells. We next
evaluated the effect of CHOP KD on b-cell survival. As
compared with non-transfected cells or cells transfected with
a control siRNA (siCtrl), transfection with CHOP siRNA#1 or
#2 had no effect on basal apoptosis, but it partly prevented
apoptosis of INS-1E cells (50% reduction) induced by a 15-h
treatment with cytokines or CPA (Figure 1d). This protection,
however, was lost in INS-1E cells treated for 24 h with TNF-a
þ IFN-g or IL-1bþ IFN-g (Supplementary Figure S3A). Similar
experiments were performed in FACS-purified primary
b-cells. Primary cell transfection using CHOP siRNA#1 fully
prevented TNF-aþ IFN-g- or IL-1bþ IFN-g-induced CHOP
mRNA expression (Figure 1e). FACS-purified primary b-cells
are more resistant to cytokine-induced apoptosis than
INS-1E cells.9 We tested the effect of CHOP KD on primary
b-cells apoptosis after 24 and 48 h of cytokines exposure
(IL-1bþ IFN-g or TNF-aþ IFN-g). The CHOP siRNA#1 fully
protected b-cells against apoptosis after 24 h (Figure 1f), but
this protection was partial and not significant in b-cells treated
for 48 h (Supplementary Figure S3B), indicating that both in
INS-1E and primary b-cells, CHOP KD induces a transient
protection against cytokine-induced apoptosis. CHOP was
also knocked down in dispersed primary human islet cells
using two different siRNAs. The percentage of CHOP KD was
68±12 and 63±14% for siCHOP#1 and siCHOP#2 (data not
shown), respectively. The siCHOP#1 significantly protected
human cells against apoptosis induced by a 48-h TNF-aþ
IFN-g treatment and there was a tendency toward a protective
effect of siCHOP#2 (Figure 1g).
Western blot analyses showed that knocking down CHOP
partly prevents cleavage of caspase 3 and 9 induced by a 15-h
treatment with IL-1bþ IFN-g or TNF-aþ IFN-g (Figure 2),
confirming the protection against cytokines. Cytokine-induced
JNK activity is involved in b-cell apoptosis7 and cytokine-
induced CHOP expression in b-cells is regulated at least
in part by JNK.18 We performed a time-course analysis of
IL-1bþ IFN-g-induced CHOP in the presence or absence
of the chemical JNK inhibitor SP600125.14 JNK inhibition
partly, but significantly, hindered CHOP overexpression after
15 and 24 h of treatment, thus confirming that cytokine-
induced CHOP overexpression is partly JNK-dependent
(Supplementary Figure S4A). On the other hand, knocking
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down CHOP did not modify IL-1bþ IFN-g-induced P-JNK and
total JNK expression (Supplementary Figure S4B).
We next tested the impact of CHOP KD on b-cell function.
Knocking downCHOP did not affect basal- (1.67mM glucose)
or glucose- stimulated insulin secretion (GSIS; 16.7mM)
under control conditions. In addition, CHOP KD did
not prevent inhibition of the GSIS induced by a 15-h
treatment with IL-1bþ IFN-g (Supplementary Figure S5),
indicating dissociation between the anti-apoptotic effects
(Figures 1d, f, g) and functional effects of CHOP KD.
The Bcl-2 protein family controls the intrinsic pathway of
apoptosis.5 The anti-apoptotic proteins Bcl-2 and B-cell
lymphoma-extra large (Bcl-XL) have been shown to antag-
onize b-cell apoptosis19–21 and we recently demonstrated
that degradation of the anti-apoptotic protein Mcl-1 contri-
butes to cytokine-induced b-cell death.14 Mcl-1 and Bcl-2
expression were decreased in INS-1E cells after a 15- or 24-h
exposure to IL-1bþ IFN-g (Figure 3). Knocking down CHOP
prevented the early (15 h) but not the late (24 h) decrease of
Bcl-2 (Figure 3a) and Mcl-1 (Figure 3b) expression. Similar
results were obtained in INS-1E cells treated with TNF-aþ
IFN-g (data not shown). Several pro-apoptotic BH3-only
proteins, including PUMA,22 DP-5,23 Bid24 and BIM,25
contribute to cytokine-induced b-cell death. Knocking down
CHOP had no effect on the induction of these genes following
an 8- or 15-h treatment with IL-1bþ IFN-g or TNF-aþ IFN-g
(Supplementary Figures S6A–F). Knocking down CHOP did
not significantly affect the mRNA expression ofBcl-2 andMcl-1
either (Supplementary Figures S6G and H), suggesting that
the effects of CHOP onBcl-2 andMcl-1 are not transcriptional.
Cytokines decrease Mcl-1 expression through the combined
action of translation inhibition (through PERK-mediated eIF2a
phosphorylation) and increased degradation via JNK activa-
tion.14 On the other hand, CHOP exerts a retroactive effect on
eIF2a phosphorylation through induction of the phosphatase
GADD34/PP1. We evaluated the impact of CHOP KD on
eIF2a phosphorylation. Surprisingly, knocking down CHOP
did not exacerbate cytokine-induced eIF2a phosphorylation
Figure 1 CHOP knockdown protects against cytokine-induced b-cell apoptosis. (a) Representative time-course experiment of CHOP protein expression in INS-1E cells
treated with IL-1bþ IFN-g (left panel) or TNF-aþ IFN-g (right panel). (b) Time-course analyses of CHOP mRNA expression in human islets exposed to TNF-aþ IFN-g
(squares) or IL-1bþ IFN-g (circles). Data are means±S.E.M. of three to five independent experiments. *Po0.05, **Po0.01 versus non-treated condition.
(c) Representative western blot of CHOP over tubulin expression in INS-1E untransfected (NT) or transfected with a control siRNA (siCtrl), or two different CHOP siRNA
(siCHOP#1 and #2) and treated (þ ) or not ( ) for 15 h with CPA. Data are means±S.E.M. of four independent experiments. (d) INS-1E cells were untransfected (NT, black
bars), transfected with siCtrl (stripe bars), siCHOP#1 (white bars), or siCHOP#2 (dotted bars), and treated for 15 h with IL-1bþ IFN-g, TNF-aþ IFN-g or CPA as indicated.
(e and f) FACS-purified primary b-cells were transfected with the siCtrl (black bars) or siCHOP#1 (white bars), and treated for 24 h with IL-1bþ IFN-g or TNF-aþ IFN-g.
(e) Real-time PCR analyses of CHOP over GAPDH mRNA expression. (d and f) Prevalence of apoptosis was evaluated by HO-PI staining. (d and f) Data are mean±S.E.M.
of at least four independent experiments. *Po0.05, **Po0.01 versus respective non-treated condition. #Po0.05, ##Po0.01 versus respective untransfected and siCtrl-
transfected condition. (g) Dispersed human islet cells were transfected with the siCtrl, the human siCHOP#1, or the human siCHOP#2 and treated for 48 h with
TNF-aþ IFN-g. Prevalence of apoptosis was evaluated by HO-PI staining and expressed as the apoptotic index. Data are mean±S.E.M. of three independent experiments.
*Po0.05 versus respective siCtrl-transfected condition
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(Supplementary Figure S7). Mcl-1 protein decrease can be
prevented upon inhibition of the proteasome.14 This is also the
case for Bcl-2, as Bcl-2 protein levels are restored to control
values upon inhibition of proteosomal degradation using MG-
132 (1mM) in INS-1E cells treated for 15 h with IL-1bþ IFN-g,
TNF-aþ IFN-g, or the chemical ER stressors CPA or
thapsigargin (Figure 4a). To assess the contribution of CHOP
to Bcl-2 and Mcl-1 protein degradation, time-course experi-
ments of INS-1E cells treated with the translation inhibitor
cycloheximide were performed under control condition or in
cells treated with IL-1bþ IFN-g. Bcl-2 is known to have a long
half-life (12 h), 26 whereas Mcl-1 has a very short half-life
(30min).27 To assess Bcl-2 and Mcl-1 stability, INS-1E cells
were exposed to cycloheximide (30mM) for 4, 8 or 16 h, or for
20, 40 or 60min, respectively. Under control condition, Bcl-2
has a half-life of about 12 h (Figure 4b) and Mcl-1 of 40min
(Figure 4c). Knocking down CHOP had no impact on the half-
life of Bcl-2 and Mcl-1 in control conditions (data not shown).
To assess the impact of cytokines of the stability of the
proteins, INS-1E cells were treated for 16 and 6 h to decrease
the levels of Bcl-2 and Mcl-1, respectively. Addition of
cycloheximide to siCtrl-transfected cells led to a further
decrease in the levels of both proteins. On the other hand,
knocking down CHOP stabilized Bcl-2 (Figure 4b) and Mcl-1
(Figure 4c) proteins in INS-1E cells exposed to IL-1bþ IFN-g.
Bcl-2 and Mcl-1 are known to be degraded by the protea-
some.28We thus studied the effect of CHOPKD on the activity
of the 20S Proteasome, the catalytic core of the ATP-
dependent proteolytic complex.29 We observed that an 8- or
15-h cytokine treatment did not modify b-cells proteosomal
activity. Knocking downCHOPalso had no effect on the global
20S Proteasome activity (Supplementary Figure S8). Bcl-2
and Mcl-1 stability is regulated through poly-ubiquitination.28
We next studied the effects of cytokines and CHOP knock-
down on the expression of several E3-ligases involved in IkB-a,
Bcl-2 and Mcl-1 ubiquitination.28 IL-1bþ IFN-g induced the
expression of FBW7, FBW11, b-TRC and USP9X at 16 h in
INS-1E cells, whereas TNF-aþ IFN-g upregulated only
b-TRC. On the other hand, none of those genes were
regulated by CHOP (Supplementary Table 2).
Recent studies indicate a role for CHOP in inflamma-
tion,11–13 and we and others demonstrated that inflammation
in b-cells largely depends on NF-kB.3 We thus studied the
impact of CHOP in cytokine-induced NF-kB activity. Cyto-
kines induce an early (30min) NF-kB activation that is
sustained for 8–12 h and tends to decrease after at 24–48 h
in INS-1E cells.30 To study the potential role of CHOP in NF-
kBactivity, we use 8h of cytokine treatment, a time point when
NF-kB activity is still strong and CHOP is highly expressed.
As expected, treating INS-1E cells with IL-1bþ IFN-g or
TNF-aþ IFN-g for 8 h strongly induced the activity of a
NF-kB-responsive promoter construct (Figure 5a). Knocking
down CHOP had no effect on the basal promoter activity,
but decreased by 50% the cytokine-stimulated activity
(Figure 5a). Conversely, CHOP overexpression using a
plasmid encoding the rat CHOP (Figure 5b) increased both
the basal and cytokine-induced NF-kB activity (Figure 5c). In
line with these findings, knocking down CHOP in FACS-
purified primary b-cells significantly decreased the 24 h
cytokine-induced overexpression of iNOS (Figure 5d) and
FAS (Figure 5e), two important NF-kB target genes.31,32
iNOS (Supplementary Figure S9A) and FAS (Supplementary
Figure S9C) were similarly regulated by CHOP in INS-1E cells
after an 8-h treatment with IL-1bþ IFN-g or TNF-aþ IFN-g.
This resulted in a 20% diminution in NO production in those
cells (Supplementary Figure S9B).
NF-kB also controls several chemokine genes involved in
inflammation.3 We studied the induction of the NF-kB-
dependent chemokine (C–C motif) ligand 5 (CCL5) in primary
b-cells treated for 24 h with IL-1bþ IFN-g or TNF-aþ IFN-g,
and observed a 50% decrease in CCL5 mRNA in CHOP
knocked-down cells (Figure 6a). This was also observed
in INS-1E cells after an 8-h treatment with cytokines
(Supplementary Figure S9D) and resulted in a 50% decrease
Figure 2 CHOP knockdown protects against cytokine-induced caspase 3
and 9 cleavage. INS-1E cells were transfected with a control siRNA (siCtrl)
or siCHOP#1, and treated for 15 h with IL-1bþ IFN-g or TNF-aþ IFN-g.
(a) Representative western blot showing CHOP and the cleaved caspase 3
and 9 fragments normalized to the tubulin levels. (b) Quantitative assessment
of four independent blots. *Po0.05, **Po0.01 versus respective non-treated
condition. #Po0.05 versus respective siCtrl-transfected condition
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in CCL5 release as measured by ELISA in response to
IL-1bþ IFN-g (Figure 6b) and TNF-aþ IFN-g (Figure 6c). Of
note, the amount of CCL5 released by INS-1E cells treated
with TNF-aþ IFN-g was 10-fold higher as compared with cells
treated with IL-1bþ IFN-g. Knocking down CHOP also partly
blocked the induction of the chemokines (C-X-C motif) ligand
10 (CXCL10; Figure 6d) and the cytokine IL15 (Figure 6e) in
primary b-cells in response to TNF-aþ IFN-g, but had no effect
on the minor induction obtained in response to IL-1bþ IFN-g.
These chemokines are co-regulated by IFN regulatory factor 7
(IRF7),33 which is mostly a TNF-a-dependent gene. In line
with this, knocking down CHOP decreased TNF-aþ IFN-g-
induced IRF-7 mRNA overexpression (Figure 6f).
Both CHOP and NF-kB are transcription factors, and FAS
has been shown to be co-regulated at the promoter level by
the transcription factors C/EBPb and p65 (the active subunit of
the NF-kB complex).31 Co-immunoprecipitation experiments
failed to show a direct CHOP/p65 interaction (Figure 7a).
NF-kB activity is controlled by the IkB complex. In control
condition, p65 is sequestered in the cytosol by the IkB
complex. Upon cytokine treatment, IkB-a and b are degraded,
allowing p65 translocation to the nucleus and induction of
NF-kB target genes. In an attempt to explain the CHOP effect
on NF-kB activity, we studied the impact of CHOP on p65
translocation and the stability of the IkB complex. Knocking
downCHOPattenuated the p65 nuclear translocation induced
by an 8-h treatment with IL-1bþ IFN-g or TNF-aþ IFN-g, and
prevented IkB-a degradation (Figures 7b and c). On the other
hand, knocking down CHOP had no effect on IKK-b or IkB-b
degradation upon an 8-h cytokine treatment (Figure 7c).
Discussion
The purpose of this study was to elucidate whether CHOP
contributes to cytokine-induced apoptosis, and if so, to
determine the mechanism underlying this contribution. We
presently demonstrate that CHOP expression is induced by
cytokines, partly through JNK activation, in rodent b-cells and
human islets, and that it contributes to the early b-cell
apoptosis induced by cytokines. CHOP is involved in
cytokine-induced degradation of Bcl-2 and Mcl-1, two major
anti-apoptotic proteins involved in the control of the intrinsic
mitochondrial pathway of apoptosis. In addition, CHOP does
not alter JNK activity, but promotes the activity of NF-kB, a key
transcription factor that controls the expression of several
chemokines and cytokines, and has a major role in cytokine-
mediated b-cell apoptosis.3 Altogether, these findings indicate
that cytokines induce ER stress in rodent and human islets/
b-cells, and that cytokine-induced CHOP aggravates NF-kB-
drivenmechanisms of inflammation and apoptosis, and favors
the cytokine-induced mitochondrial apoptotic pathway.
The protective effects of knocking down CHOP on b-cell
viability were transient, which may explain the conflicting
findings in the literature concerning the involvement of CHOP
in cytokine-induced apoptosis.15–17 The intrinsic mitochon-
drial pathway of apoptosis is controlled by a delicate
equilibrium between anti-apoptotic and pro-apoptotic Bcl-2
proteins.5,34 Here we show that knocking downCHOP hinders
NF-kB activity and temporarily stabilize the anti-apoptotic Bcl-2
proteins Mcl-1 and Bcl-2. On the other hand, CHOP does not
regulate the expression of several pro-apoptotic BH3-only
proteins involved in cytokine-induced b-cell apoptosis, such
as PUMA22 DP-5,23 and BIM.25 We propose that, by
promoting Bcl-2 and Mcl-1 degradation, CHOP facilitates
the stimulatory effects of BH3-only proteins on Bax transloca-
tion from the cytosol to the mitochondria, resulting in
mitochondrial outer membrane permeabilization, release of
mitochondrial intermembrane space proteins such as cyto-
chrome c, recruitment of pro-caspase 9 to form the apopto-
some, and finally cleavage of the executioner caspase 3,
resulting in apoptosis. Together with studies in other tissues
suggesting that CHOP stimulates Bax translocation to the
mitochondria,10 the present data confirm a key role for CHOP
in the regulation of the intrinsic pathway of apoptosis and
provide new insights on the mechanism underlying CHOP
pro-apoptotic action in b-cells (Figure 8).
Figure 3 CHOP knockdown transiently protects against cytokine-induced Mcl-1 and Bcl-2 protein downregulation. (a and b) Western blot analyses of Bcl-2 (a) and
Mcl-1 (b) over tubulin in INS-1E cells transfected with a control siRNA (siCtrl) or siCHOP#1, and treated for 15 or 24 h with IL-1bþ IFN-g. Upper panels: representative
western blot. Lower panels: quantitative assessment of four independent blots. *Po0.05, **Po0.01 versus respective non-treated condition. #Po0.05 versus respective
siCtrl-transfected condition
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We previously demonstrated that Mcl-1 is targeted for
degradation upon ER stress and cytokine treatment,14 and
we presently observed that cytokines also stimulate Bcl-2
degradation by the proteasome. This is consistent with
Figure 4 CHOP knockdown stabilizes Bcl-2 and Mcl-1 proteins in INS-1E cells
treated with cytokines. (a) Representative western blot of Bcl-2 expression in
INS-1E cells exposed for 15 h to cytokines (IL-1b or TNF-a,±IFN-g, as indicated),
CPA or thapsigargin (thap), with or without the proteasome inhibitor MG-132.
Figure is representative of four independent experiments. (b) INS-1E cells were
transfected with siCtrl or siCHOP#1, and treated or not for 16 h with IL-1bþ IFN-g.
Cells were then further treated or not (time 0) for 4, 8 or 16 h with cycloheximide
(30mM) to inhibit protein synthesis. Western blot analyses of Bcl-2 over tubulin were
performed. Upper panel: representative blot. Lower panel: quantitative assessment
of four independent blots. The results were normalized by setting the time zero of
each condition as 1. *Po0.05 versus respective siCtrl-tranfected cells treated with
cytokines. (c) INS-1E cells were transfected with siCtrl or siCHOP#1, and treated
or not for 6 h with IL-1bþ IFN-g. The cells were then further treated or not (0) for
20, 40 or 60 min with cycloheximide (30 mM). Western blot analyses of Mcl-1 and
tubulin were performed. Upper panel: representative blot. Lower panel: quantitative
assessment of four independent blots. The results were normalized by setting the
time zero of each condition as 1. *Po0.05 versus respective siCtrl-transfected cells
treated with cytokines
Figure 5 CHOP knockdown decreases cytokine-induced NF-kB activity and
expression of the NF-kB target genes iNOS and FAS. (a) INS-1E cells were
transfected with a NF-kB responsive reporter construct and the control reporter
plasmid pRLSV40renilla, together with a control siRNA (black bars) or the CHOP
siRNA (white bars), and treated for 8 h with IL-1bþ IFN-g or TNF-aþ IFN-g.
Results are mean NF-kB activities±S.E.M. of six independent experiments.
(b and c) INS-1E cells were transfected with a NF-kB responsive reporter construct
and the control reporter plasmid pRLSV40renilla, together with an empty plasmid
(vector) or a plasmid encoding the rat CHOP (pCHOP). (b) Representative western
blot of CHOP over tubulin in cells treated or not for 15 h with IL-1bþ IFN-g or TNF-a
þ IFN-g, as indicated. (c) NF-kB activity after 8 h of treatment with IL-1bþ IFN-g or
TNF-aþ IFN-g. (d) FACS-purified primary b-cells were transfected with the siCtrl
(black bars) or siCHOP#1 (white bars), and treated for 24 h with IL-1bþ IFN-g or
TNF-aþ IFN-g. Real-time PCR analyses of NOS2 (d) and FAS (e) over GAPDH
mRNA expression. Results are means±S.E.M. of four independent experiments.
#Po0.05, ##Po0.01 versus respective siCtrl-transfected condition
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Figure 6 CHOP knockdown mitigates cytokine-induced expression of inflammation markers and release of CCL5. (a and d–f) FACS-purified primary b-cells were
transfected with the siCtrl (black bars) or siCHOP#1 (white bars), and treated for 24 h with IL-1bþ IFN-g or TNF-aþ IFN-g. Real-time PCR analyses of CCL5 (a), CXCL10 (d),
IL15 (e) and IRF7 (f) over GAPDH mRNA expression. (b and c) INS-1E cells were transfected with siCtrl (black lines) or siCHOP#1 (gray lines), and treated for 8 or 15 h
with IL-1bþ IFN-g (b) or TNF-aþ IFN-g (c). CCL5 release was evaluated by ELISA of the cell supernatant. All data are means±S.E.M. of at least four independent
experiments. #Po0.05 versus respective siCtrl-transfected condition
Figure 7 CHOP knockdown inhibits cytokine-induced p65 translocation and IkB-a degradation. (a and c) INS-1E cells were transfected with siCtrl or siCHOP#1 and
treated for 8 h with IL-1bþ IFN-g or TNF-aþ IFN-g. (a) Representative western blot of p65 and CHOP in total extracts (input) or after co-immunoprecipitation using anti-p65,
anti-CHOP or anti-HA antibodies. (b) p65 localization was analyzed by immunofluorescence in INS-1E cells. Data are representative of four independent experiments.
(c) Upper panel: representative western blot showing CHOP, IKK-b, IkB-b and IkB-a, normalized to the p65 levels. Lower panel: quantitative assessment of IkB-a over p65
expression of four independent blots. *Po0.05 versus respective non-treated condition. #Po0.05 versus respective siCtrl-transfected condition
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previous reports showing that Bcl-2 phosphorylation leads to
proteosomal degradation, in particular in response to ER
stress.35,36 We did not observe an effect of CHOP on the
proteasome activity, indicating that that CHOP impairs the
stability of a selected number of proteins, including Mcl-1 and
Bcl-2, through a presently unknown mechanism. E3-ligases
target proteins for degradation by the proteasome through
ubiquitination.28 Although cytokines modified the expression
of some of the E3 ligases involved in Bcl-2 and/or Mcl-1
ubiquitination, CHOP did not significantly modulate these
genes. We can’t exclude however, that CHOP is regulating
these ligases post-transcriptionally. Further studies need to
be performed to evaluate the effect of CHOP on the
ubiquination of these proteins.
McCullough et al.37 demonstrated that CHOP overexpres-
sion in rat fibroblasts decreases Bcl2 mRNA expression
through an unknown mechanism. We presently observed that
CHOP KD prevents cytokine-induced Bcl-2 protein degrada-
tion without a clear effect on Bcl-2 mRNA expression,
suggesting that CHOPmay control Bcl-2 expression at several
levels. eIF2a phosphorylation and reduced rate of protein
translation are considered as protective mechanisms prevent-
ing oxidative stress and apoptosis during ER stress.38 Thus, by
inducingGADD34, CHOPmay promote eIF2a dephosphoryla-
tion and sustained protein synthesis, leading to apoptosis.39 In
this study, CHOP KD prevented GADD34 overexpression, but
did not decrease eIF2a phosphorylation. Thus, the protective
effect of CHOP KD was not mediated by increased translation
arrest. Besides, it is unlikely that increased translation arrest
would be beneficial in our model as we recently showed that
eIF2a phosphorylation rapidly leads to decreasedMcl-1 protein
levels, contributing to b-cell apoptosis.14
Our data suggest that CHOP contributes to b-cell apoptosis
via increased cytokine-induced NF-kB activity, which, by
stimulating iNOS expression, mediates NO production and
ER stress in b-cells. C/EBP family members may interact with
NF-kB subunits.40 The major NF-kB component induced by
cytokines in b-cells is the p65/p65 dimmer,3 and it was
conceivable that CHOP stimulates NF-kB activity by interact-
ing with p65. Our data, however, indicate that there is no direct
interaction between p65 and CHOP in response to cytokines.
We observed that CHOP induces NF-kB activity by promoting
IkB-a degradation and subsequent p65 translocation to the
nucleus. This is in accordance with a recent study document-
ing that C/EBPb can stimulate p65 translocation and NF-kB
activity by inhibiting LPS-induced IkB-a overexpression in
HeLa cells.41 IkBa degradation is mediated via ubiquitination
by the E3 ligase b-TRC.28 Here we show that IL-1bþ IFN-g
stimulate b-TRC expression, but that CHOP does not regulate
this E3-ligase. On the other hand, our data demonstrate that
CHOP contributes to cytokine-induced A20 (TNFAIP3) over-
expression (data not shown), possibly indirectly as a result of
its impact on NF-kB activity. A20 is an ubiquitin-editing enzyme
which has both ubiquitin and deubiquitinase activities.42 Further
studies are required to verify whether A20 influences the stability
of IkBa, Mcl-1 and/or Bcl-2 proteins. Interestingly, a recent study
indicates that IKK may directly phosphorylate and inactivate
Bcl-2,43 suggesting a cross talk between the NF-kB pathway
and the Bcl-2 family. Whether or not this cross talk exists in
b-cells and is involved in the effects of CHOP on Bcl-2 and
Mcl-1 stability also remains to be clarified.
As a consequence of its effect on NF-kB activity, knocking
down CHOP led to decreased induction of several NF-kB
target genes, including iNOS, FAS and IRF-7,31,32 and
several cytokines/chemokines involved in the inflammatory
response observed during insulitis, such as IL-15, CXCL10
and CCL5.3 TNF-aþ IFN-g induces a higher expression of
these pro-inflammatory genes in b-cells than IL-1bþ IFN-g.
This was previously shown to be mediated by TNF-a-induced
IRF-7 expression.44 As CHOP modulates IRF-7 expression,
the observed effects of CHOP KD on the expression of these
chemokines probably occur through the combined decreased
activity of NF-kB and IRF-7. These data strongly suggest that
CHOP contributes to inflammation. This is in agreement with
several studies on the CHOP KO mice revealing a role for
CHOP in in vivo models of inflammation.11–13 Moreover,
CHOP KO mice are protected against diabetes induced by
multiple low-dose streptozotocin (MLDSZT).45 In contrast,
backcrossing non-obese diabetic (NOD) mice with CHOP KO
mice did not prevent diabetes, but delayed appearance of
autoantibodies.46 It is not surprising that deletion of a single
pathway of apoptosis fails to protect NOD mice against a
massive T-cell-specific attack. The observed protection
against MLDSZT45 is also in line with our previous report
showing that inhibiting NF-kB activity in b-cells protect mice
against MLDSZT-induced diabetes.47
In conclusion, our study suggests that cytokines induce ER
stress in rodent and human islets/b-cells, and that CHOP
Figure 8 Scheme depicting the role of CHOP cytokine-induced NF-kB activity
and apoptosis. Pro-inflammatory cytokines stimulate NF-kB activity and JNK
phosphorylation, leading to NO production and ER stress, and resulting in eIF2a
phosphorylation and CHOP expression. In turn, CHOP facilitates the degradation of
IkBa, thereby amplifying NF-kB activity. CHOP also contributes to the degradation
of the anti-apoptotic proteins Bcl-2 and Mcl-1, leading to activation of the
mitochondrial pathway of apoptosis. Furthermore, the impact of CHOP on NF-kB
activity may contribute to inflammatory processes triggered by cytokines in b-cells,
putatively aggravating insulitis
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induction has a dual role in promoting b-cell death in T1D. On
one hand, CHOP directly contributes to cytokine-induced b-cell
apoptosis by promoting activation of pro-apoptotic NF-kB-
dependent pathways (i.e., NO production) and regulating
mitochondrial-mediated apoptosis (i.e., via the degradation of
the anti-apoptotic proteins Bcl-2 andMcl-1). On the other hand,
the effect of CHOP on NF-kB activation and subsequent
cytokine/chemokine expression may amplify the chemoattrac-
tion of mononuclear cells to the islets during insulitis aggravat-
ing local production of pro-inflammatory cytokines (Figure 8).
Materials and Methods
Materials. The following chemicals were purchased from Sigma-Aldrich
NV/SA (Bornem, Belgium) and used as indicated: MG-132 (1mM), cyclopiazonic
acid (CPA 20mM), thapsigargin (100 nM) and SP600125 (10mM) were dissolved in
DMSO; cycloheximide (30mM) was prepared in absolute ethanol. The following
cytokine concentrations were used: recombinant human IL-1b (R&D systems,
Abingdon, UK) at 10 U/ml in INS-1E cells, and 50 U/ml in rat primary b-cells and
human islets; recombinant rat IFN-g (R&D systems) at 100 U/ml (0.0072mg/ml) in
INS-1E cells and 1000 U/ml (0.036mg/ml) in rat primary b-cells;9,14 recombinant
human IFN-g (PreproTech, Rocky Hill, NJ, USA) at 1000 U/ml in human islets.
Recombinant human TNF-a (R&D systems) at 1000 U/ml in INS-1E cells, rat
primary cells and human islets. The selected concentrations of ER stressors and
cytokines are based on our previous dose–response studies from our group.9
Cell culture. The rat insulinoma cell line INS-1E (kindly provided by Professor
Claes Wollheim, CMU, University of Geneva) was maintained in the complete
RPMI 1640 medium as previously described.9 Male Wistar rats (Charles River
Laboratories, Brussels, Belgium) were housed and handled according to the
guidelines of the Belgian Regulations for Animal Care; all performed experiments
were approved by the local Ethical Committee. Rat islets were isolated by
collagenase digestion followed by hand picking under a stereomicroscope. Islets
were then dispersed, and primary b-cells were purified by auto-FACS (FACS Aria,
BD Bioscience, San Jose, CA, USA).48 The preparations used in the present study
contained 90.1±3.8% b-cells (n¼ 11). FACS-purified b-cells were pre-cultured in
complete b-cell medium supplemented with 5% heat-inactivated fetal bovine
serum (FBS) from 20 to 48 h for recovery. Experiments were then conducted in
medium without serum.9
Human islets were isolated from six (mRNA experiments) and four (viability
experiments) non-diabetic organ donors (age 57±5 years; BMI 26±1 kg/m2) in
Pisa, Italy, with the approval of the local ethics committee. Islets were isolated by
enzymatic digestion and density-gradient purification, and cultured in M199 medium
containing 5.5 mmol/l glucose. The human islets were shipped to Brussels within
1–5 days of isolation. After overnight recovery in Ham’s F-10 containing 6.1 mmol/l
glucose, 10% FBS, 2 mmol/l GlutaMAX, 50 mmol/l 3-isobutyl-1-methylxanthine, 1%
BSA, 50 units/ml penicillin and 50 mg/ml streptomycin, islets were exposed to
cytokines in the same medium without FBS for 24–48 h. For viability experiments,
islets were dispersed before siRNA transfection. The percentage of b-cells,
examined in the dispersed islet preparations by staining with anti-insulin antibody
(1 : 1000; Sigma-Aldrich) and donkey anti-mouse IgG rhodamine (1 : 200; Lucron
Bioproducts, De Pinte, Belgium), was 53±6%.
In selected experiments, the cell culture supernatants were collected for
determination of nitrite concentration (nitrite is a stable product of NO oxidation)
using the Griess method.
Western blot analysis. Cells were washed once with cold PBS and directly
lysed with Laemmli buffer. Preparation of nuclear extracts from INS-1E cells were
performed as described previously.49 Lysates were then resolved by SDS-PAGE
and transferred to a PVDF membrane. Immunoblot analyses were performed as
previously described14,49 using the following antibodies: polyclonal anti-rat Mcl-1
from Biovision (Gentaur, Brussels, Belgium); polyclonal anti-CHOP/GADD153,
polyclonal anti-Bax; polyclonal anti-IkBa or b; polyclonal anti-p65; polyclonal anti-
IKKa from Santa Cruz Biotechnology (Tebu-Bio nv, Boechout, Belgium);
polyclonal anti-P-eIF2a, polyclonal anti-cleaved caspase 3 or 9, polyclonal anti-
Bcl-2, polyclonal anti P-JNK and total JNK from Cell Signaling (Boston, MA, USA);
monoclonal anti-a-tubulin and horseradish peroxidase-conjugated goat anti-rabbit
or anti-mouse IgG from Sigma-Aldrich.
RNA interference. The siRNAs used in this study are described in
Supplementary Table 1.
The Allstars Negative Control siRNA (Qiagen, Venlo, The Netherlands) has
no effect on b-cell gene expression and viability.50 The siRNA transfection
was conducted according to a protocol developed in our laboratory,50
using DharmaFECT 1 or lipofectamin 2000 (Invitrogen, Paisley, UK) with a
final concentration of 30 nM siRNA. The efficiency of transfection is 490%.50
siRNA transfection under this conditions do not affect b-cell function.14 Cells were
then cultured for a 48-h recovery period before being collected or treated as
indicated.
Assessment of cell viability. The percentage of viable, apoptotic and
necrotic cells was determined using the DNA-binding dyes propidium iodide (PI,
5mg/ml) and Hoechst 33342 (HO, 5 mg/ml, Sigma-Aldrich).9 The cells were
examined by inverted fluorescence microscopy (Axiovert 200, Carl Zeiss,
Zaventem, Belgium). A minimum of 500 cells was counted in each experimental
condition by two independent observers, one of them unaware of sample identity.
In human islets experiments, cell viability was expressed as the apoptotic index
calculated as [(% apoptotic cells in experimental conditions% apoptotic cells in
control)/(100–dead cells in control)] 100.30
mRNA extraction and quantitative RT-PCR. Poly(A)þ mRNA was
isolated from INS-1E cells or dispersed islet cells using the Dynabeads mRNA
DIRECT kit (Invitrogen) and reverse transcribed as previously described.9
Quantitative PCR was performed using the IQ SYBR Green Supermix (BIO-RAD,
Nazareth Eke, Belgium), in an IQ5 instrument (BIO-RAD). Expression values were
corrected for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The presently utilized cytokines or ER stressors do not modify GAPDH
expression in insulin-producing cells under the present experimental conditions.44
The primers used in this study are described in Supplementary Table 1.
Immunofluorescence. INS-1E cells grown on glass culture slides (BD
Biosciences Europe, Erembodegem, Belgium) were fixed for 15 min in fresh 4%
paraformaldehyde, rinsed in PBS and permeabilized for 5 min in PBS-Triton X-100
0.1%. Slides were then blocked using PBS goat serum 5% and incubated
overnight at 4 1C in the presence of polyclonal rabbit anti-p65 (Santa Cruz
Biotechnology, Tebu-Bio nv). Cells were washed and further exposed for 1 h to
Alexa fluor 488-conjugated antibodies (1/1000; NV Invitrogen SA). After washing,
slides were mounted and photographed using fluorescence microscopy (Axio
Imager, Carl Zeiss).
Insulin secretion measurements. Insulin secretion assay was performed
in INS-1E cells as previously described.14 Briefly, transfected cells were incubated
for 30 min in glucose-free INS-1E medium, then washed and pre-incubated for
30 min in glucose-free KRBH buffer. Cells were then incubated for 30 min in KRBH
supplemented with 1.67 mM glucose or 16.7 mM glucose. Insulin release and
content were measured using the High Range Rat Insulin ELISA according to
manufacturer’s instruction (Mercodia AB, Uppsala, Sweden).
Co-immunoprecipitation. INS-1E cells (2 106) were washed in PBS and
resuspended in ice-cold IP cell lysis buffer (20 mM Tris (pH 7.5), 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM Na3VO4, protease inhibitor cocktail complete (Roche
Applied Science, Vilvoorde, Belgium) and 1 mM PMSF). Cell lysates were then
sonicated on ice and microcentrifuge for 10 min at 14 000 g, 4 1C. Supernatants
were pre-cleared using protein-agarose beads (Santa Cruz Biotechnology,
Tebu-Bio nv) for 1 h at 4 1C. The protein concentration of the supernatants was
determined by BCA protein assay (Thermo Fisher Scientific, Perbio Science,
Erembodegem, Belgium) and adjusted to 1 mg/ml. Protein lysate (100mg) was
incubated with 2 mg of CHOP, p65 or HA antibody overnight at 4 1C. The protein–
antibodies complexes were then immunoprecipitated using protein-agarose beads
for 2 h at 4 1C. The beads were then washed five times with IP cell lysis buffer,
resuspended in three times laemmli sample buffer, and loaded on a 12% SDS-
PAGE.
Proteasome activity. Proteasome activity was determined using the 20S
Proteasome Activity Assay Kit (Millipore (Chemicon), Brusselsesteenweg,
Belgium) according to the manufacturer’s instruction, using a Victor2 microplate
reader (PerkinElmer, Zaventem, Belgium).
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Promoter reporter assays. INS-1E cells were cotransfected using lipofect-
amine 2000 (Invitrogen) with the internal control pRL-CMV encoding Renilla luciferase
(Promega, Madison, WI, USA) and the pNF-kB-Luciferase (BD Biosciences, Palo Alto,
CA, USA). After transfection (16 h), cells were exposed to cytokines for 8 h. Sample
preparation, luciferase activities and values correction were performed as described
previously.33 Transient overexpression of rat CHOP was achieved using the full-
length cDNA clone, cloned in the expression vector p-CMV-SPORT6 purchased
from Open Biosystems (clone 7932840; Thermo Fisher Scientific, Perbio Science).
Chemokine measurements. Supernatants of INS-1E cells treated with
IL-1bþ IFN-g or TNF-aþ IFN-g for 8 and 16 h were collected and used to
measurements of the chemokine CCL5 using an ELISA kit (R&D systems) as
described by the manufacturer.
Statistical analysis. Data are presented as means±S.E.M. Comparisons
were performed by two-tailed paired Student’s t-test or by ANOVA, followed by
t-tests with Bonferroni correction for multiple comparisons. A P-value r0.05 was
considered statistically significant.
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